Volume 141, Issue 2, Pages (May 2016)

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

High-Risk Human Papillomavirus–Positive Lung Cancer: Molecular Evidence for a Pattern of Pulmonary Metastasis Robert A.A. van Boerdonk, MSc, Johannes.

M. Arbyn, P. J. F. Snijders, C. J. L. M. Meijer, J. Berkhof, K

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening C. Tamalet, L. Le.

Volume 148, Issue 1, Pages (January 2018)

Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia A. Gradíssimo Oliveira, C. Delgado,

A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens Iris Babion, Barbara C. Snoek,

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

Volume 149, Issue 3, Pages (June 2018)

Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia A. Gradíssimo Oliveira, C. Delgado,

Volume 148, Issue 1, Pages (January 2018)

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus T. Bärnighausen, D.E. Bloom, E.T. Cafiero,

The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.

Volume 150, Issue 1, Pages (July 2018)

The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.

Are patients willing to travel for better ovarian cancer care?

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Volume 148, Issue 1, Pages (January 2018)

A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L

Volume 151, Issue 1, Pages (October 2018)

Volume 5, Issue 1, Pages e45-e58 (January 2018)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 145, Issue 2, Pages (May 2017)

Volume 138, Issue 1, Pages (July 2015)

Vulvar intraepithelial neoplasia: Risk factors for recurrence

Volume 144, Issue 2, Pages (February 2017)

Volume 135, Issue 1, Pages (October 2014)

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei

Volume 136, Issue 2, Pages (February 2015)

L.M. Bean, F.J. Sulzmaier, D.D. Schlaepfer

Volume 142, Issue 3, Pages (September 2016)

DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease Mansour.

Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer E.N. Prendergast,

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

High-Risk Human Papillomavirus–Positive Lung Cancer: Molecular Evidence for a Pattern of Pulmonary Metastasis Robert A.A. van Boerdonk, MSc, Johannes.

Volume 152, Issue 1, Pages (January 2019)

The origins of multidisciplinary cancer care

Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) C. Popadiuk, A.J. Coldman,

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

HPV vaccines – A review of the first decade

Volume 147, Issue 1, Pages (October 2017)

Cervical excisional treatment of young women: A population-based study

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis Chunqing Lin,

Volume 152, Issue 1, Pages (January 2019)

Clinical Gastroenterology and Hepatology

Volume 130, Issue 3, Pages (September 2013)

Volume 130, Issue 1, Pages (July 2013)

Volume 153, Issue 1, Pages (April 2019)

Volume 142, Issue 3, Pages (September 2016)

Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after.

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled.

Table of contents The Journal for Nurse Practitioners

Characteristics of primary peritoneal serous carcinoma in a U. S

Volume 147, Issue 3, Pages (December 2017)

Volume 12, Issue 6, Pages (December 2005)

Volume 152, Issue 1, Pages (January 2019)

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Interobserver reproducibility of the assessment of severity of complaints, grip strength, and pressure pain threshold in patients with lateral epicondylitis

Volume 153, Issue 3, Pages (June 2019)

Fig. 3. The examinations consumed by the three cervical screening strategies to detect CIN2+/CIN3+. (A) The cases of CIN2+ detected by three current cervical.

Volume 154, Issue 2, Pages (August 2019)

Volume 154, Issue 1, Pages (July 2019)

Presentation transcript:

Volume 141, Issue 2, Pages 341-347 (May 2016) Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush- based self-samples to detect cervical (pre)cancer in HPV-positive women Lise M.A. De Strooper, Viola M.J. Verhoef, Johannes Berkhof, Albertus T. Hesselink, Helena M.E. de Bruin, Folkert J. van Kemenade, Remko P. Bosgraaf, Ruud L.M. Bekkers, Leon F.A.G. Massuger, Willem J.G. Melchers, Renske D.M. Steenbergen, Peter J.F. Snijders, Chris J.L.M. Meijer, Daniëlle A.M. Heideman Gynecologic Oncology Volume 141, Issue 2, Pages 341-347 (May 2016) DOI: 10.1016/j.ygyno.2016.02.012 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 Overview of the study populations. The training and validation sets for lavage self-samples (1A), and the training and validation sets for brush self-samples (1B) are presented. HPV=human papillomavirus, CIN=cervical intraepithelial neoplasia. Gynecologic Oncology 2016 141, 341-347DOI: (10.1016/j.ygyno.2016.02.012) Copyright © 2016 The Authors Terms and Conditions

Fig. 2 Reproducibility of the ΔΔcq ratios of FAM19A4 (A) and mir124-2 (B) between two independent qMSP runs. Gynecologic Oncology 2016 141, 341-347DOI: (10.1016/j.ygyno.2016.02.012) Copyright © 2016 The Authors Terms and Conditions